Evidence map›Paper›PMID 39707433›Full record

ArticleWorld journal of surgical oncology2024

Evaluating functional outcomes and quality of life in musculoskeletal tumor patients with distal femoral megaprostheses: a case-control study.

Nadia Jover-Jorge, Paula González-Rojo, José Vicente Amaya-Valero, Francisco Baixuali-García, Carolina de la Calva-Ceinós, Manuel Ángel Angulo-Sánchez, Juan Francisco Lisón, Javier Martínez-Gramage

Abstract read
In one paragraph

Article in World journal of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Total femur replacement: function, quality of life, and gait: a multicentric EMSOS study.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nadia Jover-JorgeDepartment of Orthopedic Surgery and Traumatology, Hospital Universitario y Politécnico la Fe, Valencia, Spain.
Paula González-RojoInstituto de Investigación sanitaria la Fe, Orthopedic Surgery and Traumatology Research Group, Valencia, Spain.
José Vicente Amaya-ValeroHead of Musculoskeletal Tumors, Department of Orthopedic Surgery and Traumatology, Hospital Universitario y Politécnico la Fe, Valencia, Spain.
Francisco Baixuali-GarcíaHead of the Department of Orthopedic Surgery and Traumatology, Hospital Universitario y Politécnico la Fe, Valencia, Spain.
Carolina de la Calva-CeinósMusculoskeletal Tumor Unit, Department of Orthopedic Surgery and Traumatology, Hospital Universitario y Politécnico la Fe, Valencia, Spain.
Manuel Ángel Angulo-SánchezMusculoskeletal Tumor Unit, Department of Orthopedic Surgery and Traumatology, Hospital Universitario y Politécnico la Fe, Valencia, Spain.
Juan Francisco LisónDepartment of Biomedical Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain. juanfran@uchceu.es.
Javier Martínez-GramageDepartment of Physiotherapy, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.

Funding

Universidad CEU Cardenal Herrera GIR24/13
6 · The paper itself

Abstract

backgroundEndoprosthetic knee replacement using megaprostheses has become a common strategy for preserving joint function in patients with distal femur tumors. While existing literature has primarily focused on surgical techniques, complications, and implants, recent improvements in patient survival rates have sparked increased interest in the long-term functional outcomes associated with this treatment.

methodsThis case-control study evaluated functional outcomes-Timed Up and Go (TUG), 6-Minute Walk Test (6MWT), knee flexor and extensor muscle strength, and sagittal knee range of motion-and health-related quality of life (SF-36) between patients with distal femoral megaprostheses (n = 31) and healthy controls (n = 48). Participants performed the TUG and 6MWT equipped with an inertial measurement unit. Additionally, bivariate Spearman correlations were calculated within the patient group to assess relationships between Musculoskeletal Tumour Society (MSTS) scores and functional outcomes.

resultsPatients performed significantly worse than controls in the TUG test, with longer completion times (Mean Difference: -3.3 s; 95% CI: -5.7 to -0.9; p = 0.008), reduced rotational speed during the middle turn (Mean Difference: 16°/s; 95% CI: 7 to 25; p < 0.001) and final turn (Mean Difference: 22°/s; 95% CI: 9 to 34; p < 0.001), and lower vertical acceleration during the Sit-to-Stand phase (Mean Difference: 1.3 m/s²; 95% CI: 0.1 to 2.5; p = 0.032). In the 6MWT, patients walked 86 m less on average than controls (95% CI: 35 to 136; p = 0.002). Knee range of motion was significantly reduced, with median flexion of 90.2° (range: 5-125) in patients versus 136.4° (range: 115-150) in controls (p < 0.001, Z = -7.268). Muscle strength was also markedly lower in patients (p < 0.001). The SF-36 revealed significant differences in the Physical Component Summary (Mean Difference 95% CI: 15.5 [10.0 to 20.9]; p < 0.001), while no significant differences were found in the Mental Component Summary (p > 0.05). In patient group, bivariate Spearman correlations indicated a very strong positive association between MSTS scores and knee extension strength (ρ = 0.710; p < 0.001), and strong positive correlations with sagittal knee range of motion (ρ = 0.472; p = 0.015), total walking distance in 6MWT (ρ = 0.474; p = 0.019), and final turn rotational speed in TUG (ρ = 0.439; p = 0.032).

conclusionOur findings demonstrate a strong association between knee extensor strength and range of motion with overall functional performance, as reflected in MSTS scores. While nearly 75% of patients achieved scores classified as "good" to "excellent," objective measures from the TUG and 6MWT revealed significant performance deficits compared to healthy controls, likely due to limitations in knee extensor strength and range of motion. These results highlight the need for targeted rehabilitation strategies focused on enhancing muscle strength and range of motion to optimize long-term functional recovery in these patients.

Indexed as

Quality of LifeRange of Motion, ArticularAdultArthroplasty, Replacement, KneeBone NeoplasmsCase-Control StudiesFemaleFemoral NeoplasmsFemurFollow-Up StudiesHumansKnee JointKnee ProsthesisMaleMiddle AgedMuscle StrengthCase-control studyDistal femurFunctional mobilityLower limbMegaprosthesisMusculoskeletal tumorQuality of life

Identifiers

PMID39707433
PMCPMC11662794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.